DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Shemaroo Entertainment Limited — Outcome of Board Meeting

NSE 1 hr ago·2 Nov 2026, 12:14 pm

Shemaroo Enter

Shemaroo Entertainment Limited has informed the stock exchange regarding its financial results for the quarter ended September 30, 2026. The company has submitted these updates to ensure transparency and compliance with market regulations. This filing marks the standard disclosure of its performance during this period.

For investors, this update is a key indicator of the company's current operational health and financial trajectory. It provides a snapshot of how Shemaroo is performing in its core business segments, helping shareholders assess the company's progress against previous expectations.

Investors should monitor the specific details within the filing, such as revenue growth and profitability metrics. Keeping an eye on future guidance and market trends will be essential to understanding the broader implications of these results for the company's stock.